Evidence map›Paper›PMID 39438361›Full record

ReviewArchives of osteoporosis2024

The essential role of combined calcium and vitamin D supplementation in the osteoporosis scenario in italy: Expert opinion paper.

Stefano Carugo, Fabio Vescini, Andrea Giusti, Giulia Letizia Mauro, Laura Tafaro, Francescaromana Festuccia, Lucia Muraca, Paolo Menè, Maurizio Rossini

Abstract readReview
In one paragraph

Review in Archives of osteoporosis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stefano CarugoDepartment of Clinical Sciences and Community Health, University of Milan, 20122, Milan, Italy.
Fabio VesciniEndocrinology Unit University Hospital of Udine, Udine, Italy.
Andrea GiustiDivision of Internal Medicine, Department of Medicine & Cardiology, "Villa Scassi" Hospital, Genoa, Italy, ASL3, 16132, Genoa, Italy.
Giulia Letizia MauroDepartment of Precision Medicine in the Medical, Surgical and Critical Care Area (Me.Pre.C.C.), University of Palermo, 90127, Palermo, Italy.
Laura TafaroDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Francescaromana FestucciaDivision of Nephrology, Sant'Andrea University Hospital, Rome, Italy.
Lucia MuracaDepartment of Primary Care, ASP Catanzaro, 88100, Catanzaro, Italy.
Paolo MenèDivision of Nephrology, Sapienza University of Rome, Sant'Andrea University Hospital, Rome, Italy.
Maurizio RossiniDepartment of Medicine, Rheumatology Unit, University of Verona, Verona, Italy. maurizio.rossini@univr.it.ORCID 0000-0001-9692-2293

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An Italian multidisciplinary working group discussed the current Italian scenario of osteoporosis management during a meeting and highlighted the essential role of calcium and vitamin D supplementation in the prevention of fragility fractures. PURPOSE: This paper aims to review and discuss data on calcium and vitamin D requirements and the role of combined calcium and vitamin D supplementation in the treatment of patients with osteoporosis.

methodsThe discussion of the experts covered literature data on calcium and vitamin D supplementation, gaps in the diagnosis and treatment of osteoporosis, and the role of the primary care physician in identifying and treating patients with osteoporosis. Articles for consideration were identified through PubMed searches using different combinations of pertinent keywords.

resultsThe discussion highlighted that insufficient calcium or vitamin D intake increases the risk of fragility fractures. The experts also drew attention to the essential role of calcium and vitamin D supplementation in achieving an anti-fracture effect and supporting the efficacy of anti-osteoporotic agents without increasing nephrolithiasis and cardiovascular risks. In addition, the discussion underlined the role of the primary care physician in the initial clinical approach to patients with osteoporosis.

conclusionsThe experts believe that efficient treatment for patients with osteoporosis should include calcium and vitamin D supplementation to achieve adequate levels that are able to inhibit the parathyroid hormone and bone resorption.

Indexed as

CalciumDietary SupplementsOsteoporosisVitamin DBone Density Conservation AgentsHumansItalyOsteoporotic FracturesBone Density Conservation AgentsCalciumVitamin DCardiovascular riskFragility fracture preventionNephrolithiasis riskOsteoporosis; calciumVitamin D

Identifiers

PMID39438361
PMCPMC11496317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.